200
Participants
Start Date
July 15, 2024
Primary Completion Date
December 30, 2026
Study Completion Date
June 30, 2032
Neoadjuvant Chemotherapy combined with Neoadjuvant Radiotherapy
Neoadjuvant radiotherapy: whole-breast irradiation ( 50 Gy in 25 fractions) plus a mandatory boost (14 Gy in seven fractions, which began on the day following completion of whole-breast irradiation) TCb (HP) \* : Triple negative patients will receive TCb regimens with or without immunotherapy and HER2 positive patients will receive TCb(HP) regimens.
Tianjin medical university cancer institute and hospital, Tianjin
The First Affiliated Hospital of Zhengzhou University
OTHER
The First Affiliated Hospital of Hainan Medical University
OTHER_GOV
Shandong Cancer Hospital and Institute
OTHER
First Affiliated Hospital of Kunming Medical University
OTHER
Chongqing University Cancer Hospital
OTHER
Tangshan People's Hospital
OTHER
Taizhou Hospital
OTHER
Tianjin Medical University Cancer Institute and Hospital
OTHER